Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Erik H.J.G. Aarntzen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3809-0182; OpenAlex author ID A5035000626. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers

Papers 8

  1. Qualitative flow metabolic phenotype of pancreatic cancer. A new prognostic biomarker? First author DOI 10.1016/j.hpb.2023.11.010↗
  2. Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer. Last author DOI 10.2967/jnumed.123.266262↗
  3. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.molpharmaceut.3c00453↗
  4. Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1007/s00261-021-03190-w↗
  5. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Co-author DOI 10.1038/s41467-021-27088-9↗
  6. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-022-00298-5↗
  7. Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2021.07.23.452145↗
  8. Optimal respiratory-gated [18F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patie… Last author DOI 10.1186/s13550-019-0492-y↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. E. Smeets · 6 shared papers, 2019–2024 · strength 0.76
  2. Martin Gotthardt · 4 shared papers, 2019–2024 · strength 0.68
  3. Jens Thomas Siveke · 5 shared papers, 2021–2024 · strength 0.66
  4. Marija Trajkovic‐Arsic · 4 shared papers, 2021–2024 · strength 0.56
  5. John J. Hermans · 3 shared papers, 2019–2024 · strength 0.50
  6. Phyllis F. Cheung · 4 shared papers, 2021–2023 · strength 0.46
  7. Lodewijk A.A. Brosens · 2 shared papers, 2024 · strength 0.41
  8. Rickmer Braren · 3 shared papers, 2021–2024 · strength 0.39
  9. Cees J. H. M. van Laarhoven · 2 shared papers, 2019–2024 · strength 0.32
  10. Smiths Lueong · 3 shared papers, 2021–2022 · strength 0.30
  11. Erwin J. M. van Geenen · 1 shared paper, 2024 · strength 0.22
  12. Deniece Rivière · 1 shared paper, 2024 · strength 0.22
  13. David Kuang-Fu Chang · 1 shared paper, 2024 · strength 0.22
  14. Andrea Tannapfel · 2 shared papers, 2021–2022 · strength 0.20
  15. Waldemar H. Uhl · 2 shared papers, 2021–2022 · strength 0.20
  16. Irina Heid · 2 shared papers, 2021–2022 · strength 0.20
  17. Stephan A. Hahn · 2 shared papers, 2021–2022 · strength 0.20
  18. Laura Godfrey · 2 shared papers, 2021–2022 · strength 0.20
  19. Jörg D. Hoheisel · 2 shared papers, 2021–2022 · strength 0.20
  20. T. H. Perik · 1 shared paper, 2022 · strength 0.19
  21. HenkJan J. Huisman · 1 shared paper, 2022 · strength 0.19
  22. Christian Klein · 1 shared paper, 2023 · strength 0.17
  23. Sanne A. M. van Lith · 1 shared paper, 2023 · strength 0.17
  24. Daphne N. Dorst · 1 shared paper, 2023 · strength 0.17
  25. Martijn W.J. Stommel · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.